Capital International Investors 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-12-10 4:09 pm Unchanged | 2021-12-10 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 1,462,465 4.900% | 0 (Unchanged) | Filing |
| 2021-12-10 2:34 pm Sale | 2021-12-10 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 1,462,465 4.900% | -1,514,024 (-50.87%) | Filing |
| 2021-10-08 12:10 pm Unchanged | 2021-10-12 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,976,489 10.000% | 0 (Unchanged) | Filing |
| 2021-10-08 12:03 pm Purchase | 2021-10-12 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,976,489 10.000% | 396,034 (+15.35%) | Filing |
| 2021-02-16 2:24 pm Unchanged | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,580,455 8.700% | 0 (Unchanged) | Filing |
| 2021-02-16 1:57 pm Purchase | 2021-02-16 | 13G | Quince Therapeutics, Inc. QNCX | Capital International Investors | 2,580,455 8.700% | 2,580,455 (New Position) | Filing |